SEC adopts EDGAR Next - As outlined in this October 22 Cooley alert, the Securities and Exchange Commission (SEC) adopted final ...
After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...
STAT+ subscribers can sign up here to get it delivered to their inbox. As we count down toward the December readout of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback